December 13, 2016 / 9:30 PM / 2 years ago

BRIEF-Pershing Square updates on sale of Valeant Pharmaceuticals shares by its onshore partnerships

* Pershing Square Capital Management says sold common stock of Valeant Pharmaceuticals International for accounts of PS and PS II, the two onshore partnerships

* Pershing Square Capital Management - PS and PS II sold, respectively, 3.4 million shares and 117,512 shares of high-cost-basis common stock of valeant pharmaceuticals

* Pershing Square says PS international and PSH, the two offshore funds, sold no shares of Valeant Pharmaceuticals’ common stock

* Pershing Square says in addition, it purchased to close, for the accounts of the Pershing Square funds, the $165.00 strike call options that the funds previously sold short in November 2015

* Pershing Square says the sale of Valeant stock was in order to generate a tax loss in 2016 for their investors

* Pershing Square Capital Management reports it owns 7.8 percent stake in valeant pharmaceuticals international as of dec 12 - SEC filing Source text:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below